Comparison of the Effects of Artemisia Vaginal Cream and Clotrimazole on Vaginal Candidiasis Infection

Open access


Candida vaginitis is the second most common vaginal infection which is treatable by azole. Overconsumption of azole is associated with resistance to drug and treatment failure. Studies conducted in laboratory conditions confirm the anti-fungal effects of Artemisia plant. The aim of this study was to compare the effect of vaginal Artemisia cream and clotrimazole on vaginal candidiasis infection. This is a clinical triple-blind trial that was performed on 72 non-pregnant women referred to Mashhad health centers in 2012-2017. After confirmation of Candida infection, the research units were randomly allocated into two groups: Artemisia and clotrimazole vaginal cream recipients treated for 7 nights. After the treatment, the data were analyzed by SPSS software (version 24). The results of the study showed that the mean reduction in the score of signs and symptoms of vaginal Candida infection was 7.4 ± 4. 1 and 7.6 ± 3.8 in the Artemisia and clotrimazole group, respectively. Wilcoxon test showed that improvement in both groups treated by Artemisia and clotrimazole was significantly higher than before treatment (p < 0.001). There was no significant difference between the two groups regarding the improvement of symptoms (p > 0.05). Acta facultatis medicae Naissensis 2018; 35(4):299-310 The present study showed that Artemisia vaginal cream and clotrimazole cream both improved the symptoms related to vaginal Candida infection. In addition, the therapeutic effect of the two drugs was not statistically significant in comparison with each other. Therefore, it can be used as an alternative treatment for vaginal candidiasis.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Berek JS N. Berek & Novak's Gynecology. B.Gj editor: 4; 2007.

  • 2. Kissner RW. Gynecology: Principles and Practice 6th. ed. 1995:38-44.

  • 3. Brooks GF Butel JS Morse SA. Medical microbiology. United States 25th. 2006.

  • 4. Dharmik PG Gomashe AV Upadhyay VG. Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis. J Obstet Gynaecol India 2013;63(2):135-75.

  • 5. Karaca M Bayram A Kocoglu ME Gocmen A Eksi F. Comparison of clinical diagnosis and microbiological test results in vaginal infections. Clin Exp Obstet Gynecol 2005;32(3):172.

  • 6. Rylander E Berglund A Krassny C Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with orogenital sex and frequent pain at intercourse. Sex Transm Infect 2004;80(1):54-7.

  • 7. Maharlouei NBE Sharif F Hosseini H Lankarani K. Prevalence and risk factors of reproductive tract infections among a defined population of Iranian women. Sex Health 2013;10(4):311-5.

  • 8. Hedayati MT Taheri Z Galinimoghadam T et al. Isolation of Different Species of Candida in Patients With Vulvovaginal Candidiasis From Sari Iran. Jundishapur J Microbiol 2015;8:e15992.

  • 9. Emami SA Asili J Eynolghozat R et al. Chemical Composition and In Vitro Efficacy of Essential Oil of Seven Artemisia Species Against ESBL Producing Multidrug-Resistant Escherichia coli. Journal of Essential Oil Bearing Plants2015;18(1):124-45.

  • 10. Khanjani N Zamanian M Molazadeh P Sadeghi M. The Prevalence of Candida Albicans Infection and Related Factors in Women Referring to Health Centers of Jiroft in 2010: A Short Report. J Rafsanjan University of Medical Sciences 2014;13(6):569-76.

  • 11. Johal HS Garg T Rath G Goyal AK. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv 2016;23(2):550-63.

  • 12. Fule SR Das D Fule RP. Detection of phospholipase activity of Candida albicans and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area. Indian J Med Microbiol 2015;33(1):92-5.

  • 13. Mendling W Brasch J Cornely OA et al. Guideline: vulvovaginal candidosis (AWMF 015/072) S2k (excluding chronic mucocutaneouscandidosis). Mycoses 2015;58:1-15.

  • 14. Brandolt TM Klafke GB Goncalves CV et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol 2017;48(1):145-50.

  • 15. Katiraee F Eidi S Bahonar A et al. Comparision of MICs of some Iranian Herbal Essences Against Azole Resistance and Azole Susceptible of Candida Albicans. J Med Plants 2008; 3: 37-44.

  • 16. Santomauro F Donato R Sacco C et al. Vapour and Liquid-Phase Artemisia annua Essential Oil Activities against Several Clinical Strains of Candida. Planta Med 2016;82(11-12):1016-20.

  • 17. Yigit D Yigit N Ozgen U. An investigation on the anticandidal activity of some traditional medicinal plants in Turkey. Mycoses 2009;52(2):135-40.

  • 18. Juteau F Jerkovic I Masotti V et al. Composition and antimicrobial activity of the essential oil of Artemisia absinthium from Croatia and France. Planta Med 2003;69(2):158-61.

  • 19. Hemati M. Using plants in the prevention and treatment of diseases. Tehran: office of islamic culture publication 2015.

  • 20. Weathers PJ Towler M Hassanali A et al. Driedleaf Artemisia annua: A practical malaria therapeutic for developing countries. World J Pharmacol 2014;3(4):39-55.

  • 21. Asili J Emami SA Eynolghozat R et al. Chemical Composition of Essential Oil of Seven Artemisia Species Against ESBL Producing Multidrug-Resistant Escherichia coli. J Essential Oil Bearing Plants 2015;18(1):124-45.

  • 22. Ghlissi Z Sayari N Kallel R et al. Antioxidant antibacterial anti-inflammatory and wound healing effects of Artemisia campestris aqueous extract in rat. Biomed Pharmacother 2016; 84:115-22.

  • 23. Yun C Jung Y Chun W et al. Anti-Inflammatory Effects of Artemisia Leaf Extract in Mice with Contact Dermatitis In Vitro and In Vivo. Mediators of Inflammation 2016;18(1):135-45.

  • 24. Nosrati M Behbahani M. Antibacterial Activity of Methanol Extracts from Different Parts of Prangoscrossoptera and their Synergistic Effect on Some Antibiotics. J Mazandaran University of Medical Sciences 2015;25:92-101.

  • 25. Sun X Sun H Zhang J Ji X. Artemisia Extract Improves Insulin Sensitivity in Women With Gestational Diabetes Mellitus by Up-Regulating Adiponectin. J Clin Pharmacol 2016; 56: 1550-4.

  • 26. Tan J Zhang J Chen W et al. The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia. Mycopathologia 2015;179:213-8.

  • 27. Zhang X Liu ZH. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans]. Zhonghuafuchankezazhi 2016;51:279-84.

  • 28. Fouladi Z Afshari P Gharibi T Dabbagh MA. The compareson oF Zataria multiflora boiss (Avishan Shirazi) and Clotrimazol vaginal cream in the treatment of candidiasis vaginitis. Iranian South Medical J 2009;12:214-24.

  • 29. Ribnicky DM Roopchand DE Poulev A et al. Artemisia dracunculus L. polyphenols complexed to soy protein show enhanced bioavailability and hypoglycemic activity in C57BL/6 mice. Nutrition 2014; 30:S4-10.

  • 30. Boudjelal A Siracusa L Henchiri C et al. Antidiabetic Effects of Aqueous Infusions of Artemisia herba-alba and Ajugaiva in Alloxan-Induced Diabetic Rats. Planta Med 2015;81:696-704.

  • 31. Mulatu A Mekonnen Y. Spasmolytic effects of artemisiaafra and artemisiarehan in tissue preparations. Ethiop Med J 2007;45(4):371-6.

  • 32. ZamanaiTaghizadehRabe S Iranshahi M Rastin M et al. In vitro immunomodulatory properties of a sesquiterpene lactone-bearing fraction from Artemisia khorassanica. J Immunotoxicol 2015;12(3):223-30.

  • 33. Hakimi M A Mirjalili F. An investigation into biological activities of A. persica's essential oil. Pajouhesh & Sazandegi Yazd University 2003;16:2-5.

  • 34. Heshmati P AA. Comprehensive dictionary of generic drugs and herbal Iran along with nursing care - medical and dental considerations Tehran: Andisherafie2010: 1008.

  • 35. Bahadoran P Rokni FK Fahami F. Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran J Nurs Midwifery Res 2010;15:343-9.

  • 36. Hazrati A IM Zarei MA Abaspour M. The effect of clotrimazole vaginal cream and licorice in the treatment of candida vaginitis: Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran 2008.

  • 37. Kordi M JN Rakhshandeh H Gholami H. Comparison of the effect of garlic extract vaginal douche and clotrimazol vaginal cream in the treatment of women with vaginal candidiasis. Iran J Reprod Med 2005;8(2): 33-42.

  • 38. Mousavi MSA Pakshir KA Yazdani MA et al. Comparison of the effects of bee propolis cream clotrimazole vaginal cream in the treatment of fungal infections of the vagina in women of childbearing age. J Isfahan Medical School 2011;28 (117):1099-107.

  • 39. Roozbahani F Kariman N Mojab F Nasiri M. Effect of Myrtuscommunis capsule on vaginal candidiasis treatment. Pajoohandeh J 2013;18(5):242-9.

  • 40. Janani F AS Delfan B Toulabi T et al. A Comparative study of effect of myrtus vaginal cream and clotrimazol vaginal cream in the treatment of vaginal candidiasis. Scientific magazine yafte 2011; 13(1): 32-41.

Journal information
Impact Factor

Cite Score 2018: 0.33

SCImago Journal Rank (SJR) 2018: 0.134
Source Normalized Impact per Paper (SNIP) 2018: 0.287

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 234 234 10
PDF Downloads 208 208 19